Product Images Fluticasone Propionate And Salmeterol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 18 images provide visual information about the product associated with Fluticasone Propionate And Salmeterol NDC 0093-7517 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - image 1

1 - image 1

2 - image 10

2 - image 10

Figure D - image 11

Figure D - image 11

Figure E - image 12

Figure E - image 12

1 - image 13

1 - image 13

Figure G - image 14

Figure G - image 14

1 - image 15

1 - image 15

1 - image 16

1 - image 16

This appears to be a description of a medication, specifically Fluticasone Propionate and Salmeterol Inhalation Powder, used for oral inhalation. Each blister contains 100 micrograms of Fluticasone Propionate, USP and 725 micrograms of Salmeterol Xinafoate USP equivalent to 50 micrograms of Salmeterol base with lactose. The text provides instructions on how to use the medication and proper breathing techniques. The manufacturer of the medication is Teva. No information is given on side effects or medical conditions this medication is designed to treat.*

1 - image 17

1 - image 17

1 - image 18

1 - image 18

This is a medication label for Fluticasone Proplonate and Salmeterol Inhalation Powder, USP. It contains instructions on how to use the inhaler and the dosage. The medication is used for inhalation only and comes in a pack of 60 blisters. The label includes precautions and potential side effects.*

1 - image 2

1 - image 2

1 - image 3

1 - image 3

This appears to be a medication prescription for Fluticasone Propionate and Salmeterol inhalation powder. It indicates a dosage of 100 micrograms of Fluticasone Propionate and 50 micrograms of Salmeterol to be taken twice daily. The following section seems to be a chart showing the results of a study where Fluticasone Propionate and Salmeterol were compared to Placebo. Unfortunately, due to the quality of the text obtained by , certain characters are corrupted and the nature of the study or the parameters of the chart are not clear.*

1 - image 4

1 - image 4

1 - image 5

1 - image 5

1 - image 6

1 - image 6

This is a clinical study evaluating the effects of Fluticasone propionate and salmeterol inhalation powder compared to a Placebo on lung function measured by FEV. The study involved patients taking either Fluticasone propionate and salmeterol inhalation powder, Salmeterol, or Placebo twice daily for a period of time indicated by the graph. The results suggest that Fluticasone propionate and salmeterol inhalation powder may improve lung function compared to Placebo.*

1 - image 7

1 - image 7

1 - image 8

1 - image 8

1 - image 9

1 - image 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.